In summary, DDR represented by phosphorylation of H2AX, ATM, and CHK2 is a highly sensitive tool to identify patients with AT that can be readily distinguished from patients with other combined immunodeficiencies. This evidence concerns the gene CHEK2 and ataxia telangiectasia.